Caris Life Sciences Inc. (NASDAQ:CAI) is one of the best IPO stocks with huge upside potential. On July 1, Caris Life announced the commercial launch of Caris Detect, a multi-cancer early detection ...
A machine learning program that identified patients overdue for colorectal cancer screening helped increase screening rates ...
Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...
Colorectal cancer is associated with certain microbiomes that produce microbial signatures that can be detected by a ...
Strand Life Sciences secures Indian patent for early cancer detection platform using cfDNA analysis from a single blood ...
Caris Life Sciences ® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine ...
A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient's risk of hepatocellular carcinoma (HCC), the most common ...
2don MSN
Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection
The patented platform combines genome sequencing, methylation analysis and machine learning to detect cancer and identify its ...
Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...
Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results